Piperacetazine and Chlorpromazine: A Comparison
Abstract
Twenty-six agitated acute schizophrenic patients in a state hospital received intramuscular injections of either piperacetazine or chlorpromazine. Three rating scales were used to assess the effects of the drugs. Both drugs were found to be effective in producing significant improvement in the patients. Piperacetazine appeared to be more potent than chlorpromazine. No side effects were observed.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).